fatigue

[키워드] acid acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adverse effect adverse effects age ambulatory ambulatory patient ambulatory patients ascorbic acid benefit Care Chain Reaction clinical clinical trial Combination conditional power conducted coronavirus cough COVID cumulative deaths decrease diagnosed diagnosis of SARS-CoV-2 duration of symptom early treatment Effect end point enrolled Evidence fatigue Fever finding group groups health system High-dose hospitalizations Identifier Importance Infection Length mitigate multicenter no significant difference not affect objective Open-label open-label trial participant Patient Point polymerase chain polymerase chain reaction prescribed medications primary end point progression Randomized randomized clinical trial receive receiving reduce reduction in Registration Relevance required respiratory Result SARS-CoV-2 SARS-COV-2 infection secondary secondary outcome Secondary outcomes setting severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severity Shortness of breath significant difference significantly Standard of care Symptom symptom severity score Symptoms Treatment treatment groups Trial Trial registration usual care women Zinc zinc gluconate
[DOI] 10.1001/jamanetworkopen.2021.0369 PMC 바로가기 [Article Type] Randomized Controlled Trial